Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
PCC
Pharmacologic Management of TBI
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
PCC
Neuropsychiatric Complications of Hypervitaminosis D
PCC
Impact of Disability on Medical Care
PCC
Management of Rumination and Obsessions in Primary Care

Page 20

More PCC Articles

JCP
The Epidemiology and Global Burden of Schizophrenia
JCP
Optimizing Therapy Selection, Sequencing in Schizophrenia
JCP
Defining and Achieving Treatment Recovery in Schizophrenia
JCP
Atomoxetine and Prevalence of Major Congenital Malformations
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ January 16, 2023

Little is known about the safety of atomoxetine, a non-stimulant treatment for attention-deficit/hyperactivity disorder. This study assessed the prevalence of major congenital malformations after first-trimester exposure to atomoxetine.
JCP
Community Navigation Service for People With Serious Mental Illness
JCP
Actualizing and Sustaining Recovery-Oriented Care
JCP
Cognitive Impairment, Reward Pathways and Treatment Challenges in Schizophrenia Video
JCP
Treating Schizophrenia: Side Effects and Adherence Video
JCP
Sequencing Therapy in the Treatment of Schizophrenia Video
JCP
Shared Decision Making in Schizophrenia Treatment Video
JCP
TMS in Anxious Depression
JCP
A Message of Appreciation From the Editor